PATENT CLAIM ANALYSIS

Application Number: 16292005
Application Type: Utility
Filing Date: 2019-03
Publication Date: 2019-09
Patent Classification: ["514", "04400A"]

Abstract:
The invention relates to a nucleic acid molecule that binds and/or is complementary to the nucleotide molecule having sequence 5′GUGGCUAACAGAAGCU (SEQ ID NO 1) and to its use in a method for inducing skipping of exon 44 of the DMD gene in a DMD patient.

Claim (Index 3):
The antisense oligonucleotide according to  claim 1 , comprising a 2\u2032-O-alkyl phosphorothioate antisense oligonucleotide.

Metadata:
- Claim Count in Document: 18.0
- Percentile: 99.0
- Lexical Diversity: 1.23077
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14859598', '12992218', '14631686', '15232493', '14542183']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7695017629639063
- 35 USC 102 Novelty (BERT): 0.6394054360621151
- Combined Prediction Score: 0.7564921302737272
- Mean Citation Score: 508.489814
- Max Citation Score: 606.8151
- Similarity Product: 581.5094963825762

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test